Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Microb Pathog ; 119: 86-92, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29604422

RESUMEN

The aim of this study was to investigate the protective effects and mechanism of isovitexin, a glycosylflavonoid isolated from rice hulls of Oryza sativa, on Lipopolysaccharide (LPS)/d-galactosamine (D-Gal)-induced acute liver injury. The mice were randomly divided into five groups: control group, LPS/D-Gal group, and LPS/D-Gal + isovitexin groups. The mice of LPS/D-Gal group were received of LPS (50 µg/kg) and D-gal (800 mg/kg) intraperitoneal. The mice of LPS/D-Gal + isovitexin groups were received isovitexin (25, 50, 100 mg/kg) 1 h before LPS/D-Gal treatment. The results showed that the severity of liver injury was attenuated by treatment of isovitexin, as confirmed by the decreased liver histopathologic changes, as well as serum AST and ALT levels. Furthermore, the levels of TNF-α in serum and liver tissues, MPO activity and MDA content were significantly inhibited by isovitexin. In addition, isovitexin significantly attenuated NF-κB phosphorylation induced by LPS/D-Gal. The expression of Nrf2 and HO-1 were significantly up-regulated by isovitexin. In conclusion, isovitexin could protect against LPS/D-Gal-induced liver injury by inhibiting inflammatory and oxidative responses. Isovitexin also had protective effects against carbon tetrachloride (CCl4)-induced liver injury. Isovitexin may used as a potential agent for the treatment of liver injury.


Asunto(s)
Apigenina/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Galactosamina/efectos adversos , Lipopolisacáridos/efectos adversos , Hígado/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , FN-kappa B/efectos de los fármacos , Animales , Apigenina/administración & dosificación , Tetracloruro de Carbono/efectos adversos , Galactosamina/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Hemo-Oxigenasa 1/metabolismo , Lipopolisacáridos/administración & dosificación , Pruebas de Función Hepática , Masculino , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , FN-kappa B/metabolismo , Oryza/química , Fosforilación , Extractos Vegetales/farmacología , Transducción de Señal/efectos de los fármacos , Factor de Necrosis Tumoral alfa/sangre , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA